|
Volumn 28, Issue 16, 2010, Pages 2802-2804
|
Certain death in uncertain time: Informing hope by quantifying a best case scenario
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BICALUTAMIDE;
GOSERELIN;
MITOXANTRONE;
PROSTATE SPECIFIC ANTIGEN;
ZOLEDRONIC ACID;
ADULT;
ADVANCED CANCER;
BONE PAIN;
CANCER MORTALITY;
CANCER SURVIVOR;
CASE REPORT;
DEATH;
GLEASON SCORE;
HOPE;
HUMAN;
LIFE EXPECTANCY;
MALE;
MULTIPLE CYCLE TREATMENT;
PALLIATIVE THERAPY;
PRIORITY JOURNAL;
PROGNOSIS;
PROSTATE ADENOCARCINOMA;
PROSTATE BIOPSY;
QUALITY OF LIFE;
SHORT SURVEY;
SURVIVAL TIME;
TREATMENT RESPONSE;
ATTITUDE TO DEATH;
DISEASE FREE SURVIVAL;
DOCTOR PATIENT RELATION;
FEMALE;
INTERPERSONAL COMMUNICATION;
LIFE TABLE;
MORTALITY;
NEOPLASM;
PREDICTION AND FORECASTING;
PSYCHOLOGICAL ASPECT;
REVIEW;
STATISTICS;
SURVIVAL;
SURVIVOR;
TIME;
ATTITUDE TO DEATH;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
LIFE EXPECTANCY;
LIFE TABLES;
MALE;
NEOPLASMS;
PHYSICIAN-PATIENT RELATIONS;
PREDICTIVE VALUE OF TESTS;
SURVIVAL ANALYSIS;
SURVIVORS;
TIME FACTORS;
TRUTH DISCLOSURE;
|
EID: 77954912822
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2009.27.3326 Document Type: Short Survey |
Times cited : (43)
|
References (8)
|